📖 Approx. 7 min read ／ Updated 2026.05.08
M&A for medium to large hospitals, unlike the typical business succession of general clinics, is characterized by its deep involvement with contributions to regional healthcare, maintenance of public health, and a complex regulatory environment. In particular, national policies such as the regional healthcare vision and bed function realignment significantly influence the success or failure of these transactions, making specialized knowledge of the healthcare industry indispensable. This article will explain the key issues and keys to success in M&A for medium and large hospitals for directors and presidents of medical corporations, those considering the acquisition of medical institutions, and professionals involved in medical succession.
Specifics and Market Trends of M&A for Medium and Large Hospitals
M&A involving medium-sized hospitals with 100 or more beds, or large hospitals with over 500 beds, often involve transactions ranging from several billion to tens of billions of yen. This signifies not just the sale and purchase of assets, but the succession of critical infrastructure supporting the foundation of regional healthcare. The overall market is seeing M&A driven by various factors, including the aging of healthcare professionals, a shortage of successors, aging facilities, and realignment pressures associated with the regional healthcare vision.
Regarding the valuation of transfer prices, 4 to 7 times EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is often considered a general benchmark. However, this is merely a guideline, and it can fluctuate significantly depending on the hospital’s medical functions, its role in the region, its management status, future prospects, and negotiation dynamics. Potential acquirers include existing medical corporation groups seeking to expand their scale, corporations affiliated with medical consulting firms aiming for management improvement, and fund-based investors pursuing business revitalization investments. In these transactions, the type of medical corporation (e.g., with or without equity interests) of the target hospital greatly impacts the scheme and taxation, making careful consideration in the initial stages essential.
Impact of Regional Healthcare Vision and Bed Function Realignment on M&A
The regional healthcare vision is a national policy aiming to optimize the healthcare delivery system in each region with a view to 2025, and it is one of the most critical issues in M&A for medium and large hospitals. The vision categorizes hospital beds into five functions: “highly acute care,” “acute care,” “recovery care,” “chronic care,” and “community-based integrated care,” and defines the necessary number of beds for each. When considering M&A, it is essential to closely coordinate with administrative bodies to confirm which bed function the target hospital falls under and what future realignment direction is required.
If M&A involves a change in bed function, prior consultation and approval from the regional health bureaus and prefectural governments are mandatory. This involves strict examination of facility standards, staffing levels, and medical equipment, and often requires obtaining new licenses or modifying existing ones. M&A that aligns with the regional healthcare vision not only meets regional healthcare needs but can also lead to adaptation to future medical fee revisions and the establishment of a stable management base. Conversely, M&A with low consistency with the vision carries the risk of administrative guidance or disapproval, necessitating a strategic approach by experts.
Handling of Medical Corporation Forms, Equity Interests, and Funds
In Japan, there are various types of medical corporations, including “medical corporations with equity interests,” “medical corporations without equity interests,” “special medical corporations,” and “social medical corporations,” each with significantly different legal and tax treatments in M&A. Particularly in the case of “medical corporations with equity interests,” which were once mainstream, the equity interests held by members (shareholders) are evaluated as de facto property rights, and the transfer of these interests forms the core of M&A transactions.
The transfer of equity interests incurs capital gains tax, and the amount of tax significantly affects the transaction price. Furthermore, changes in membership require amendments to the articles of incorporation and approval from the general meeting of members, and the calculation of the equity interest valuation requires specialized knowledge. On the other hand, in the case of “medical corporations without equity interests” or “fund-contributing medical corporations,” since there are no equity interests, the main issues are the change of members and the refund or succession of funds. In the case of fund-contributing corporations, funds are generally only refunded upon the dissolution of the corporation, but succession of funds or contribution of new funds may be considered during a change of membership accompanying M&A. Establishing an appropriate M&A scheme tailored to the form of these corporations and accurately grasping the tax implications, including business tax and capital gains tax, is extremely important for smooth succession.
Impact of Medical Fee Revisions, Facility Standards, and Licenses on M&A Valuation
Hospital management is constantly affected by medical fee revisions, which occur every two years. The direction of these revisions, particularly the medical fields that are emphasized and those that are suppressed, directly impacts a hospital’s revenue structure and is therefore a crucial factor in forecasting future revenue in M&A. Acquirers rigorously evaluate how well the target hospital is adapted to the current medical fee system and whether it has the capacity to flexibly respond to future revision trends.
Furthermore, to provide specific medical services, facilities must meet the standards set by the Ministry of Health, Labour and Welfare. For example, facility standards for acute care wards and rehabilitation wards, corresponding to their bed functions, are strictly defined, and whether these standards can be maintained or improved in the post-M&A management plan is a key item in due diligence. The status of existing licenses (establishment permits based on the Medical Care Act, notifications for each medical department, etc.) and the possibility of needing to obtain new licenses after M&A also affect the feasibility and schedule of the transaction. Compliance with these medical regulations indicates the hospital’s compliance system, requiring appropriate evaluation and risk management.
Securing Doctors, Nurses, and Other Healthcare Professionals, and Personnel/Organizational Restructuring
One of the most valued assets in hospital M&A is the doctors, nurses, and other healthcare professionals working there. In particular, the continued intention of full-time doctors and specialists is directly linked to the stability of hospital operations and the maintenance of medical functions after M&A, and is therefore examined in detail during due diligence. The departure of key physicians can lead to difficulties in maintaining medical departments or failing to meet facility standards for medical fees, posing a significant risk to both the seller and the buyer.
Personnel and organizational restructuring after M&A involves the challenging task of maintaining the motivation of existing healthcare professionals and fostering a new organizational culture. Changes in salary systems, benefits, career paths, and the work environment significantly impact the retention rate of healthcare professionals, requiring careful communication and meticulous personnel strategies from the M&A planning stage. Additionally, relationships with medical departments and the situation of securing doctors in the region can be important factors influencing the success of M&A. Respecting the expertise and experience of healthcare professionals and providing an environment where they can continue to work with peace of mind leads to an increase in hospital value after M&A.
M&A Execution Process and Tax/Legal Considerations
The M&A process for medium and large hospitals typically takes about 6 months to a year and involves multiple experts, making it a complex journey. First, after signing a Non-Disclosure Agreement (NDA), the valuation of the target hospital and matching with potential acquirers are conducted. Subsequently, a Letter of Intent (LOI) is signed following top-level meetings. At this stage, basic agreement on terms between the seller and buyer is formed.
One of the most critical phases is detailed due diligence (DD). Risks and opportunities of the target hospital are thoroughly investigated from various aspects, including financial, tax, legal, human resources, medical, real estate, and environmental. Particularly for medical institutions, key points such as the appropriateness of medical fee claims, compliance with facility standards, validity of licenses, medical malpractice risks, and consistency with the regional healthcare vision are重点的に確認されます (thoroughly examined).
From a tax perspective, significant taxes may arise, such as the treatment of consumption tax and real estate acquisition tax in the case of business transfer, and capital gains tax associated with the transfer of medical corporation equity interests. From a legal perspective, procedures specific to the Medical Care Act are required, such as amendments to the articles of incorporation, approval from the board of directors and general meeting of members, and notifications/approvals to administrative agencies. To smoothly proceed with these complex processes, support from a team of experts such as lawyers, tax accountants, and M&A advisors well-versed in medical M&A is indispensable.
M&A for medium and large hospitals requires extensive specialized knowledge and careful procedures due to their social responsibility and the complexity of their operations. To overcome unique challenges such as responding to the regional healthcare vision, complex medical corporation structures, and securing healthcare professionals, the specialized expertise of M&A support organizations focused on the healthcare industry is essential. MA Medical has abundant experience and know-how in M&A and business succession for medical institutions. If you have any questions regarding the future of your hospital or new medical developments, please feel free to use our free consultation service.
Consultation on Medical Succession with MA Medical
MA Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the successful transfer of clinics and medical corporations struggling with a lack of successors, as well as strategic acquisitions, on a success fee basis.
- Initial consultation and preliminary assessment are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeding under NDA)
- Services available nationwide in all 47 prefectures and for all medical specialties
Please consult with us early, even if you only want to know the market price, have no successor, or are considering joining a group.